Biomarin Pharmaceutical Inc

Ownership Transactions Reported by 23 Insiders

Symbol
BMRN on Nasdaq
Industry
Pharmaceutical Preparations
Location
105 Digital Drive, Novato, California

Insiders trading volume in the past year

Biomarin Pharmaceutical Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Jean Jacques Bienaime Director $55.6M -$12.7M -18.6% May 20, 2024
Henry J. Fuchs President, Worldwide R&D $16.5M -$3.01M -15.4% Mar 15, 2024
Alexander Hardy Chief Executive Officer, Director $13.1M Mar 15, 2024
Richard A. Meier Director $9.23M Jun 3, 2024
Elaine J. Heron Director $7.47M Jun 3, 2024
Charles Greg Guyer EVP, Chief Technical Officer $6.11M May 3, 2024
Brian Mueller EVP, Chief Financial Officer $5.89M -$376K -6% Jun 28, 2024
Jeffrey Robert Ajer EVP, Chief Commercial Officer $5.54M -$763K -12.1% May 2, 2024
George Eric Davis EVP, Chief Legal Officer $4.23M -$6.69M -61.3% May 28, 2024
D. E. I. Pyott Director $3.83M May 21, 2024
V. Bryan Lawlis Director $3.19M May 23, 2023
Robert J. Hombach Director $2.71M May 21, 2024
Dennis Slamon Director $2.62M Mar 18, 2024
Willard H. Dere Director $2.49M May 21, 2024
Elizabeth M. Anderson Director $2.14M May 21, 2024
Andrea Acosta GVP, Chief Accounting Officer $1.75M Apr 30, 2021
Maykin Ho Director $1.65M May 21, 2024
Cristin Hubbard EVP, Chief Commercial Officer $1.49M May 20, 2024
Mark J. Alles Director $1.45M May 23, 2023
Erin Burkhart GVP, Chief Accounting Officer $1.3M -$270K -17.2% Aug 13, 2024
Mark J. Enyedy Director $532K May 21, 2024
Athena Countouriotis Director $532K May 21, 2024
Barbara W. Bodem Director $532K May 21, 2024

Recent Insider Transactions by Companies or Individuals for Biomarin Pharmaceutical Inc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.